Cargando…
Use of the Uteroglobin Platform for the Expression of a Bivalent Antibody against Oncofetal Fibronectin in Escherichia coli
Escherichia coli is a robust, economic and rapid expression system for the production of recombinant therapeutic proteins. However, the expression in bacterial systems of complex molecules such as antibodies and fusion proteins is still affected by several drawbacks. We have previously described a p...
Autores principales: | Ventura, Elisa, Riondato, Mattia, Sambuceti, Gianmario, Salis, Annalisa, Damonte, Gianluca, Cordazzo, Cinzia, Besir, Hüseyin, Pistoia, Vito, Zardi, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868587/ https://www.ncbi.nlm.nih.gov/pubmed/24367567 http://dx.doi.org/10.1371/journal.pone.0082878 |
Ejemplares similares
-
C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8
por: Ventura, Elisa, et al.
Publicado: (2016) -
Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling?
por: David, L.
Publicado: (1996) -
Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report
por: Ventura, Elisa, et al.
Publicado: (2011) -
Uteroglobin-related protein 1 and severity of inhalation injury
por: Friedman, G, et al.
Publicado: (2015) -
Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.
por: Takano, T., et al.
Publicado: (1998)